CN Patent
CN104350056A — 端锚聚合酶的吡咯并嘧啶酮和吡咯并吡啶酮抑制剂
Assigned to F Hoffmann La Roche AG · Expires 2015-02-11 · 11y expired
What this patent protects
本发明涉及式(I)化合物,其中Q、R 1 和R 2 如本文所定义。该化合物具有作为抗癌药物的活性。
USPTO Abstract
本发明涉及式(I)化合物,其中Q、R 1 和R 2 如本文所定义。该化合物具有作为抗癌药物的活性。
Drugs covered by this patent
- Veozah (FEZOLINETANT) · Astellas Pharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.